Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04110249 · ClinicalTrials.gov registry record · NA
Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer
A NA study, sponsored by Roswell Park Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04110249 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 14 participants.
The verdict
NCT04110249, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This trial studies how well photoacoustic imaging works in measuring tumors and normal tissue in patients with head and neck cancer. Photoacoustic imaging (PAI) is a low-risk imaging method that provides information about the oxygenation of tissues using a combination of light and ultrasound techniques. This study may help doctors determine if PAI is correlated with clinical responses of both tumor (for example: shrinking, swelling or disappearing) and normal tissues (for example: skin redness, dry mouth, appearance of sores, healing of skin or mucosa). If there is a correlation with clinical responses, then doctors may develop PAI as method for measuring response to earlier treatment.
Interventions
- PROCEDURE Photoacoustic Imaging
- PROCEDURE Transcutaneous Acupoint Electrical Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-09-06 |
| Est. Completion | 2022-12-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04110249
The ClinicalTrials.gov registry entry for NCT04110249 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Photoacoustic Imaging is the first listed.
NCT04110249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04110249 about?
NCT04110249 is a clinical study titled "Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer". This trial studies how well photoacoustic imaging works in measuring tumors and normal tissue in patients with head and neck cancer. Photoacoustic imaging (PAI) is a low-risk imaging method that provides information about the oxygenation of tissues using a combination of light and ultrasound techniq...
What is the current status of trial NCT04110249?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2019-09-06. Estimated completion is 2022-12-29.
What interventions are being tested in trial NCT04110249?
The interventions under investigation include: Photoacoustic Imaging (PROCEDURE), Transcutaneous Acupoint Electrical Stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT04110249?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.